Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Enterprise Value for 7 consecutive years, with -$103.6 million as the latest value for Q1 2025.
- Quarterly Enterprise Value fell 796692.31% to -$103.6 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$103.6 million through Mar 2025, changed N/A year-over-year, with the annual reading at -$50.9 million for FY2024, 1945.34% down from the prior year.
- Enterprise Value hit -$103.6 million in Q1 2025 for Benitec Biopharma, down from -$78.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13000.0 in Q1 2024 to a low of -$103.6 million in Q1 2025.
- Historically, Enterprise Value has averaged -$26.8 million across 5 years, with a median of -$15.7 million in 2021.
- Biggest five-year swings in Enterprise Value: soared 99.8% in 2024 and later tumbled 796692.31% in 2025.
- Year by year, Enterprise Value stood at -$12.3 million in 2021, then rose by 14.72% to -$10.5 million in 2022, then plummeted by 93.91% to -$20.4 million in 2023, then crashed by 283.97% to -$78.3 million in 2024, then crashed by 32.32% to -$103.6 million in 2025.
- Business Quant data shows Enterprise Value for BNTC at -$103.6 million in Q1 2025, -$78.3 million in Q4 2024, and -$67.9 million in Q3 2024.